The Long QT Syndromes: Genetic basis and clinical implications

Journal of the American College of Cardiology

Volumn 36, Issue 1, 2000, Pages 1-12

  Chiang, Chern En ^a   Roden, Dan M ^b  

^a Division of Cardiology   (Taiwan)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIDOCAINE; MEXILETINE; NADOLOL; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; PROPANOL; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE; VERAPAMIL;

ACTION POTENTIAL; ALLELE; AUTOSOMAL DOMINANT INHERITANCE; GENE LOCUS; GENE MUTATION; GENETICS; HEART DEPOLARIZATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LONG QT SYNDROME; NONHUMAN; PERCEPTION DEAFNESS; PHENOTYPE; POTASSIUM CURRENT; PRIORITY JOURNAL; PURKINJE FIBER; REPOLARIZATION; REVIEW; SODIUM CURRENT; SUDDEN DEATH; TORSADE DES POINTES;

CARDIAC PACING, ARTIFICIAL; CATION TRANSPORT PROTEINS; DNA-BINDING PROTEINS; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MUTATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; PURKINJE FIBERS; SODIUM CHANNELS; TRANS-ACTIVATORS;

EID: 0033910376     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00716-6     Document Type: Review

References (119)

1. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the QT interval and sudden death. Am Heart J. 54:1957;59-68.
2. Romano C., Gemme G., Pongiglione R. Aritmie cardiache rare dell'eta' pediatrica. Clin Pediatr. 45:1963;656-683.
3. Ward O.C. A new familial cardiac syndrome in children. J Iri Med Assoc. 54:1964;103-106.
4. Yanowitz F., Preston J.B., Abildskov J.A. Functional distribution of right and left stellate innervation to the ventricles production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone . Circ Res. 18:1966;416-428.
5. Schwartz P.J., Malliani A. Electrical alteration of the T wave clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long QT syndrome . Am Heart J. 89:1975;45-50.
6. Schwartz P.J., Periti M., Malliani A. The long Q-T syndrome. Am Heart J. 89:1975;378-390.
7. Schwartz P.J. Idiopathic long QT syndrome progress and questions . Am Heart J. 109:1985;399-411.
8. Moss A.J., Schwartz P.J., Crampton R.S., Locati E., Carleen E. The long QT syndrome a prospective international study . Circulation. 71:1985;17-21.
9. Keating M., Atkinson D., Dunn C., Timothy K., Vincent G.M., Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey ras-1 gene. Science. 252:1991;704-706.
10. Curran M., Atkinson D., Timothy K., et al. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest. 92:1993;799-803.
11. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:1995;805-811.
12. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia HERG mutations cause long QT syndrome . Cell. 80:1995;795-803.
13. Wang Q., Curran M.E., Splawski I., et al. Positional cloning of a novel potassium channel gene KVLQT1 mutations cause cardiac arrhythmias . Nat Genet. 12:1996;17-23.
14. Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C., Keating M.T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet. 17:1997;338-340.
15. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 97:1999;175-187.
16. Schott J.J., Charpentier F., Peltier S., et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 57:1995;1114-1122.
17. Neyroud N., Tesson F., Denjoy I., et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 15:1997;186-189.
18. Splawski I., Timothy K.W., Vincent G.M., Atkinson D.L., Keating M.T. Molecular basis of the long QT syndrome associated with deafness. N Engl J Med. 336:1997;1562-1567.
19. Schulze-Bahr E., Wang Q., Wedekind H., Haverkamp W., Chen Q., Sun Y. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet. 17:1997;267-268.
20. Vincent G.M., Timothy K.W., Leppert M., Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med. 327:1992;846-852.
21. Roden D.M., Lazzara R., Rosen M., Schwartz P.J., Towbin J., Vincent M. Multiple mechanisms in the long QT syndrome. Current knowledge, gaps and future directions. Circulation. 94:1996;1996-2012.
22. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long QT Syndrome Registry Research Group. N Engl J Med. 339:1998;960-965.
23. Wilde A.A., Jongbloed R.J., Doevendans P.A., et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol. 33:1999;327-332.
24. + channel blockade and to increases in heart rate implications for gene-specific therapy . Circulation. 92:1995;3381-3386.
25. Compton S.J., Lux R.L., Ramsey M.R., et al. Genetically defined therapy of inherited long QT syndrome. Correction of abnormal repolarization by potassium. Circulation. 94:1996;1018-1022.
26. Priori S.G., Napolitano C., Schwartz P.J. Low penetrance in the long QT syndrome clinical impact . Circulation. 99:1999;529-533.
27. Neyroud N., Denjoy I., Donger C., et al. Heterozygous mutation in the pore of potassium channel gene KvLQT1 causes an apparently normal phenotype in long QT syndrome. Eur J Hum Genet. 6:1998;129-133.
28. Ackerman M.J. The long QT syndrome ion channel diseases of the heart . Mayo Clin Proc. 73:1998;250-269.
29. Fraser G.R., Froggatt P., Murphy T. Genetically aspects of the cardioauditory syndrome of Jervell and Lange-Nielsen (congenital deafness and electrocardiographic abnormalities). Ann Hum Genet. 28:1964;133-157.
30. Benhorin J., Kalman Y.M., Medina A., et al. Evidence of genetic heterogeneity in the long QT syndrome. Science. 260:1993;1960-1962.
31. Ko Y.L., Chen S.A., Tank T.K., et al. No evidence of linkage of long QT syndrome and chromosome 11p15.5 markers in a Chinese family evidence for genetic heterogeneity . Hum Genet. 94:1994;364-366.
32. Russell M.W., Dick M. II, Collins F.S., Brody L.C. KVLQT1 mutations in three families with familial or sporadic long QT syndrome. Hum Mol Genet. 5:1996;1319-1324.
33. Donger C., Denjoy I., Berthet M., et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 96:1997;2778-2781.
34. Shalaby F.Y., Levesque P.C., Yang W.P., et al. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation. 96:1997;1733-1736.
35. Tanaka T., Nagai R., Tomoike H., et al. Four novel KVLQT1 and four novel HERG mutations in familial long QT syndrome. Circulation. 95:1997;565-567.
36. van den Berg M.H., Wilde A.A., Robles de Medina E.O., et al. The long QT syndrome a novel missense mutation in the S6 region of the KVLQT1 gene . Hum Genet. 100:1997;356-361.
37. Kanters J.K., Larsen L.A., Orholm M., et al. Novel donor splice site mutation in the KVLQT1 gene is associated with long QT syndrome. J Cardiovasc Electrophysiol. 9:1998;620-624.
38. Li H., Chen Q., Moss A.J., et al. New mutations in the KVLQT1 potassium channel that cause long QT syndrome. Circulation. 97:1998;1264-1269.
39. Saarinen K., Swan H., Kainulainen K., Toivonen L., Viitasalo M., Kontula K. Molecular genetics of the long QT syndrome two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred . Hum Mutat. 11:1998;158-165.
40. Ackerman M.J., Schroeder J.J., Berry R., et al. A novel mutation in KVLQT1 is the molecular basis of inherited long QT syndrome in a near-drowning patient's family. Pediatr Res. 44:1998;148-153.
41. Franqueza L., Lin M., Splawski I., Keating M.T., Sanguinetti M.C. Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits. J Biol Chem. 274:1999;21063-21070.
42. + channel gene and identification of C-terminal mutations in the long QT syndrome. Circ Res. 84:1999;290-297.
43. Ackerman M.J., Tester D.J., Porter C.J., Edwards W.D. Molecular diagnosis of the inherited long QT syndrome in a woman who died after near-drowning. N Engl J Med. 341:1999;1121-1125.
44. Roden D.M., Spooner P.M. Inherited long QT Syndrome a paradigm for understanding arrhymogenesis . J Cardiovasc Electophysiol. 10:1999;1664-1684.
45. Priori S.G., Schwartz P.J., Napolitano C., et al. A recessive variant of the Romano-Ward long-QT syndrome? Circulation. 97:1998;2420-2425.
46. Larsen L.A., Fosdal I., Andersen P.S., et al. Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet. 7:1999;724-728.
47. Tyson J., Tranebjarg L., Bellman S., et al. IsK and KvLQT1 mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome . Hum Mol Genet. 6:1997;2179-2185.
48. Chen Q., Zhang D., Gingell R.L., et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation. 99:1999;1344-1347.
49. Jiang C., Atkinson D., Towbin J.A., et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 8:1994;141-147.
50. Warmke J.E., Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA. 91:1994;3438-3442.
51. Schulze-Bahr E., Haverkamp W., Funke H. The long-QT syndrome. N Engl J Med. 333:1995;1783-1784.
52. Salter C.A., Walsh E.P., Vesely M.R., Plummer M.H., Ginsburg R.S., Jacob H.J. Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome. Am J Med Genet. 65:1996;27-35.
53. Benson D.W., MacRae C.A., Vesely M.R., et al. Missense mutation in the pore region of HERG causes familial long QT syndrome. Circulation. 93:1996;1791-1795.
54. Li X., Xu J., Li M. The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J Biol Chem. 272:1997;705-708.
55. Nakajima T., Furukawa T., Tanaka T., et al. Novel mechanism of HERG current suppression in LQT2 shift in voltage dependence of HERG inactivation . Circ Res. 83:1998;415-422.
56. Zhou Z., Gong Q., Epstein M.L., January C.T. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 273:1998;21061-21066.
57. Chen J., Zou A., Splawski I., Keating M.T., Sanguinetti M.C. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem. 274:1999;10113-10118.
58. Berthet M., Denjoy I., Donger C., et al. C-terminal HERG mutations the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence . Circulation. 99:1999;1464-1470.
59. Hoorntje T., Alders M., van Tintelen P., et al. Homozygous premature truncation of the HERG protein the human HERG knockout . Circulation. 100:1999;1264-1267.
60. Kr potassium channel . Cell. 81:1995;299-307.
61. Furutani M., Trudeau M.C., Hagiwara N., et al. Novel mechanism associated with an inherited cardiac arrhythmia defective protein trafficking by the mutant HERG (G601S) potassium channel . Circulation. 99:1999;2290-2294.
62. McDonald T.V., Yu Z., Ming Z., et al. A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature. 388:1997;289-292.
63. + channel. Open-channel block by methanesulfonanilides. Circ Res. 78:1996;499-503.
64. Shieh M.S., Chen S.A., Chiang C.E., et al. Drug-induced torsade de pointes in one patient with congenital long QT syndrome. Int J Cardiol. 54:1996;85-88.
65. Kambouris N.G., Nuss H.B., Johns D.C., Tomaselli G.F., Marban E., Balser J.R. Phenotypic characterization of a novel long QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation. 97:1998;640-644.
66. + channel activity through interactions between alpha- and beta1-subunits. Circ Res. 83:1998;141-146.
67. + channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett. 423:1998;5-9.
68. Yamagishi H., Furutani M., Kamisago M., et al. A de novo missense mutation (R1623Q) of the SCN5A gene in a Japanese girl with sporadic long QT syndrome (abstr). Hum Mutat. 11:1998;481.
69. + channel. Circulation. 99:1999;3165-3171.
70. Wattanasirichaigoon D., Vesely M.R., Duggal P., et al. Sodium channel abnormalities are infrequent in patients with long QT syndrome identification of two novel SCN5A mutations . Am J Med Genet. 86:1999;470-476.
71. Wang Q., Li Z., Shen J., Keating M.T. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics. 34:1996;9-16.
72. Gellens M.E., George A.J., Chen L.Q., et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA. 89:1992;554-558.
73. Bennett P.B., Yazawa K., Makita N., George A.J. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 376:1995;683-685.
74. Bezzina C., Veldkamp M.W., van Den Berg M.P., et al. A single Na(+) channel mutation causing both long QT and Brugada syndromes. Circ Res. 85:1999;1206-1213.
75. Takumi T., Ohkubo H., Nakanishi S. Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science. 242:1988;1042-1045.
76. Chevillard C., Attali B., Lesage F., et al. Localization of a potassium channel gene (KCNE1) to 21q22.1-q22. 2 by in situ hybridization and somatic cell hybridization. Genomics. 15:1993;243-245.
77. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature. 384:1996;78-80.
78. Sanguinetti M.C., Curran M.E., Zou A., et al. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature. 384:1996;80-83.
79. Ks channels and channels formed with two minK mutants that cause long QT syndrome. J Gen Physiol. 112:1998;651-663.
80. Duggal P., Vesely M.R., Wattanasirichaigoon D., Villafane J., Kaushik V., Beggs A.H. Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long QT syndrome. Circulation. 97:1998;142-146.
81. Kr and trafficking in long QT syndrome . Hum Mol Genet. 8:1999;1499-1507.
82. Wang K.W., Goldstein S.A. Subunit composition of minK potassium channels. Neuron. 14:1995;1303-1309.
83. + channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res. 83:1998;95-102.
84. Kupershmidt S., Yang T., Anderson M.E., et al. Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system. Circ Res. 84:1999;146-152.
85. Marks M.L., Whisler S.L., Clericuzio C., Keating M.T. A new form of long QT syndrome associated with syndactyly. J Am Coll Cardiol. 25:1995;59-64.
86. Marks M.L., Trippel D.L., Keating M.T. Long QT syndrome associated with syndactyly identified in females. Am J Cardiol. 76:1995;744-745.
87. Tesson F., Donger C., Denjoy I., et al. Exclusion of KCNE1 (IsK) as a candidate gene for Jervell and Lange-Nielsen syndrome. J Mol Cell Cardiol. 28:1996;2051-2055.
88. Schwartz P.J., Zaza A., Locati E., Moss A.J. Stress and sudden death. The case of the long QT syndrome. Circulation. 83:(Suppl II):1991;71-80.
89. Rashba E.J., Zareba W., Moss A.J., et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation. 97:1998;451-456.
90. Locati E.H., Zareba W., Moss A.J., et al. Age- and sex-related differences in clinical manifestations in patients with congenital long QT syndrome. Findings from the International LQTS registry. Circulation. 97:1998;2237-2244.
91. Bazette H.C. An analysis of the time-relations of electrocardiograms. Heart. 7:1920;353-370.
92. Garson A.J., Dick M., Fournier A., et al. The long QT syndrome in children. An international study of 287 patients. Circulation. 87:1993;1866-1872.
93. Swan H., Viitasalo M., Piippo K., Laitinen P., Kontula K., Toivonen L. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol. 34:1999;823-829.
94. Rautaharju P.M., Zhou S.H., Wong S., et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol. 8:1992;690-695.
95. Lehmann M.H., Timothy K.W., Frankovich D., et al. Age-gender influence on the rate-corrected QT interval and the QT heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol. 29:1997;93-99.
96. Day C.P., McComb J.M., Campbell R.W. QT dispersion an indication of arrhythmia risk in patients with long QT intervals . Br Heart J. 63:1990;342-344.
97. Yan G.X., Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation. 98:1998;1928-1936.
98. Malfatto G., Beria G., Sala S., Bonazzi O., Schwartz P.J. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol. 23:1994;296-301.
99. Moss A.J., Zareba W., Benhorin J., et al. ECG T wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 92:1995;2929-2934.
100. Zhang L., Timothy K.W., Splawski I., et al. Genotypes are highly predictable in long QT syndrome families with typical ECG ST-T wave patterns (abstr). Circulation. 98:(Suppl I):1998;776.
101. Malfatto G., Rosen M.R., Foresti A., Schwartz P.J. Idiopathic long QT syndrome exacerbated by beta-adrenergic blockade and responsive to left cardiac sympathetic denervation implications regarding electrophysiologic substrate and adrenergic modulation . J Cardiovasc Electrophysiol. 3:1992;295-305.
102. Gorgels A.P., Al F.F., Zaman L., Kantoch M.J., Al H.Z. The long QT syndrome with impaired atrioventricular conduction a malignant variant in infants . J Cardiovasc Electrophysiol. 9:1998;1225-1232.
103. Shimizu W., Ohe T., Kurita T., et al. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol. 26:1995;1299-1309.
104. Dessertenne F. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur. 59:1966;263-272.
105. El-Sherif N., Caref E.B., Yin H., Restivo M. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res. 79:1996;474-492.
106. El-Sherif N., Chinushi M., Caref E.B., Restivo M. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long QT syndrome. Detailed analysis of ventricular tridimensional activation patterns. Circulation. 96:1997;4392-4399.
107. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 88:1993;782-784.
108. Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H., Keating M.T. Genomic structure of three long QT syndrome genes KVLQT1, HERG and KCNE1 . Genomics. 51:1998;86-97.
109. Schwartz P.J. The long QT syndrome. Curr Prob Cardiol. 22:1997;297-351.
110. Priori S.G., Maugeri F.S., Schwartz P.J., et al. The risk of sudden death as first cardiac event in asymptomatic patients with the long QT syndrome (abstr). Circulation. 98:(Suppl I):1998;777.
111. Eldar M., Griffin J.C., Van Hare F., et al. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol. 20:1992;830-837.
112. Priori S.G., Napolitano C., Diehl L., Schwartz P.J. Dispersion of the QT interval, a marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation. 89:1994;1681-1689.
113. Shimizu W., Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long QT syndrome effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes . Circulation. 98:1998;2314-2322.
114. + channel opener in the LQT1 form of congenital long QT syndrome. Circulation. 97:1998;1581-1588.
115. Kron J., Oliver R.P., Norsted S., Silka M.J. The automatic implantable cardioverter-defibrillator in young patients. J Am Coll Cardiol. 16:1990;896-902.
116. + channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res. 78:1996;1009-1015.
117. Shimizu W., Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation. 96:1997;2038-2047.
118. Tan H.L., Alings M., Van Olden R.W., Wilde A.A. Long-term (subacute) potassium treatment in congenital HERG-related long QT syndrome (LQTS2). J Cardiovasc Electrophysiol. 10:1999;229-233.
119. Sato T., Hata Y., Yamamoto M., et al. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome. J Cardiovasc Electrophysiol. 6:1995;279-282.